The long-term goal of this project is to elucidate the control of surfactant secretion in the newborn. Such information is vital for the prevention and/or control of the respiratory distress syndrome (RDS) in premature human newborns.
The specific aims for the proposed period of funding are twofold. First, to elucidate the mechanism by which labor stimulates surfactant production in the newborn, to determine if this effect is influenced by the sex of the newborn and if the stimulatory effect of ventilation is mediated similarly.
The second aim i s to choose agents of potential physiological significance (i.e., from the studies in Aim #1) and study in detail their effects on surfactant secretion and/or synthesis in isolated type II cells. The respiratory distress syndrome of the newborn (RDS) is still a major cause of morbidity and mortality among premature infants. RDS is a developmental disorder due to immaturity of the lung with consequent insufficient surfactant. Many studies have focused on surfactant synthesis in the fetus and a variety of hormones and other agents have been shown to accelerate surfactant production in the fetal lung. Some of these are used clinically in the prevention of RDS. Surfactant production in the newborn has been less studied. Yet it is known that a number of postnatal factors influence surfactant production and the incidence of RDS. There is a lower incidence of RDS in infants delivered after labor than in its absence. Labor has been shown to stimulate surfactant production in animal studies. Birth and ventilation are also associated with increased surfactant production. Males are more prone to RDS than females suggesting a sex difference in surfactant production.
The aim of this project is to determine how some of these factors influence surfactant secretion. In this largely biochemical study we will use the following experimental approaches to measure various parameters of surfactant production: lung lavage phospholipid content and composition; rates of precursor incorporation into specific phospholipids in lung slices; activities of enzymes of lung phospholipid biosynthesis; rate of surfactant secretion in newborn lung slices; and synthesis and secretion of surfactant in isolated type II cells. In general, the approach is to make the initial physiological observation in the intact animal, define its mechanism in the in vitro lung systems and carry out more mechanistic studies in the type II cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL031175-03
Application #
3342200
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Project Start
1984-06-01
Project End
1987-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Feng, Nan-Hsiung; Lin, Hen-I; Wang, Jinn-Shyan et al. (2005) Differential expression of a V-type ATPase C subunit gene, Atp6v1c2, during culture of rat lung type II pneumocytes. J Biomed Sci 12:899-911
Homer, Robert J; Zheng, Tao; Chupp, Geoff et al. (2002) Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 283:L52-9
Gobran, L I; Rooney, S A (2001) Regulation of SP-B and SP-C secretion in rat type II cells in primary culture. Am J Physiol Lung Cell Mol Physiol 281:L1413-9
Rooney, S A (2001) Regulation of surfactant secretion. Comp Biochem Physiol A Mol Integr Physiol 129:233-43
Isohama, Y; Rooney, S A (2001) Glucocorticoid enhances the response of type II cells from newborn rats to surfactant secretagogues. Biochim Biophys Acta 1531:241-50
Gobran, L I; Rooney, S A (1999) Surfactant secretagogue activation of protein kinase C isoforms in cultured rat type II cells. Am J Physiol 277:L251-6
Gobran, L I; Xu, Z X; Rooney, S A (1998) PKC isoforms and other signaling proteins involved in surfactant secretion in developing rat type II cells. Am J Physiol 274:L901-7
Gobran, L I; Rooney, S A (1997) Adenylate cyclase-coupled ATP receptor and surfactant secretion in type II pneumocytes from newborn rats. Am J Physiol 272:L187-96
Rooney, S A; Gobran, L I (1997) Influence of the protein kinase C inhibitor 3-[1-[3-(amidinothio) propyl]-1H-indoyl-3-yl]-3-(1-methyl-1H-indoyl-3-yl) maleimide methane sulfonate (Ro-318220) on surfactant secretion in type II pneumocytes. Biochem Pharmacol 53:597-601
Gobran, L I; Xu, Z X; Lu, Z et al. (1994) P2u purinoceptor stimulation of surfactant secretion coupled to phosphatidylcholine hydrolysis in type II cells. Am J Physiol 267:L625-33

Showing the most recent 10 out of 31 publications